Tetrabenazine
Back to searchMolecule Structure
Scientific Name
Tetrabenazine
Description of the Drug
Tetrabenazine is a vesicular monoamine transporter 2 (VMAT) inhibitor used for the management of chorea associated with Huntington’s Disease.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04844
http://www.drugbank.ca/drugs/DB04844
Brand Name(s)
Nitoman, Revocon, Tetmodis, Tetrabenazine, Xenazine, Xenazine 25
Company Owner(s)
Apotex Inc, Ajanta Pharma Ltd, Piramal Healthcare Uk Ltd, Sun Pharmaceutical Industries Ltd, Actavis Laboratories Fl Inc, Teva Branded Pharmaceutical Products R And D Inc, Dr Reddys Laboratories Ltd, Mylan Pharmaceuticals Inc, Hetero Labs Ltd Unit V, Bionpharma Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Synaptic vesicular amine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL1893 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL62026 | |||
| PharmGKB | PA140222719 | |||
| Human Metabolome Database | HMDB0015592 | |||
| DrugBank | DB04844 | |||
| PubChem: Thomson Pharma | 14975282 | |||
| PubChem | 6018 | |||
| Mcule | MCULE-5822627411 | |||
| LINCS | LSM-36891 | |||
| Nikkaji | J4.592F | |||
| BindingDB | 50017701 | |||
| EPA CompTox Dashboard | DTXSID0042614 | |||
| ChemicalBook | CB5339246 | CB92457043 | CB22545778 | |
| Guide to Pharmacology | 4834 | |||
| rxnorm | XENAZINE | AUSTEDO | DEUTETRABENAZINE | TETRABENAZINE |
| KEGG Ligand | C11168 | |||
| ChEBI | 64028 |
